Sou Hu Cai Jing·2026-01-27 03:13Consumption - Dongpeng Beverage has launched its H-share offering with a price not exceeding 248 HKD per share, expecting to end on January 29, and reported revenue exceeding 16.8 billion CNY for the first three quarters [2] - Xibei's founder, Jia Guolong, announced a return to core business focus, abandoning personal branding efforts, as the company faces losses exceeding 600 million CNY [2] - Yanghe Distillery anticipates a net profit decline of over 60% for 2025, primarily due to deep adjustments in the liquor industry and reduced market demand [2] - KFC has slightly raised prices on some delivery items by an average of 0.8 CNY starting January 26, while in-store prices remain unchanged [2] Technology - Jieyue Star has appointed Yin Qi as chairman, responsible for overall strategic direction and technology, and has reportedly completed a multi-billion B+ round of financing [2] - Samsung has raised NAND flash supply prices by 100% in Q1, indicating severe supply-demand imbalance in the semiconductor market [3] - AI chip supplier Aixin Yuanzhi has passed the Hong Kong Stock Exchange hearing [3] Health - Yiling Pharmaceutical expects a net profit of 1.2 to 1.3 billion CNY for 2025, driven by stable market performance in its cardiovascular and respiratory product lines [3] Mobility - Wuxi Xian Dao Intelligent Equipment has passed the Hong Kong Stock Exchange main board listing hearing, with CITIC Securities and JPMorgan as joint sponsors [4] - GAC Group has received nearly 2,000 orders for its GOVY AirCab by the end of 2025 [4] - Ideal Auto plans to close approximately 100 underperforming retail stores in a channel transformation effort [7] Health (Continued) - The first version of the commercial health insurance innovative drug directory took effect on January 1, 2026, aimed at providing more access to innovative drugs through commercial insurance [11] - Nine departments have issued a document encouraging innovative drugs to enter retail pharmacies, aiming to enhance the quality of the pharmaceutical retail industry [13]